
P928: REAL‐LIFE ANALYSIS OF THE MULTIPLE MYELOMA PATIENT'S SURVIVAL IN A LARGE COHORT OF PATIENTS
Author(s) -
LopezMuñoz N.,
HernandezIbarburu G.,
SánchezPina J. M.,
Alonso R. A.,
Cuellar C.,
Calbacho M.,
Ayala R.,
Iñiguez R.,
García Barrio N.,
Vera E.,
PérezRey D.,
Meloni L.,
PedreraJiménez M.,
SerranoBalazote P.,
De La Cruz J.,
MartínezLópez J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846580.48972.52
Subject(s) - medicine , lenalidomide , multiple myeloma , daratumumab , bortezomib , thalidomide , survival analysis , cohort , log rank test , statistical significance , oncology